SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTekmar Group Regulatory News (TGP)

Share Price Information for Tekmar Group (TGP)

Share Price is delayed by 15 minutes
Get Live Data
15.00    0.00 (0.00%)
Bid:
14.50
Ask:
15.50
Spread: 1.00 (6.897%)
Market Cap: £20.97m
TGP Live PriceLast checked at - London Stock Exchange

Intraday Tekmar Group Share Chart

Form 8.5 (EPT/RI)

3 Jan 2023 12:00

RNS Number : 5193L
Singer Capital Markets Sec Ltd
03 January 2023
Β 

FORM 8.5 (EPT/RI)

Β 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

Β 

1. KEY INFORMATION

Β 

(a) Name of exempt principal trader:

Singer Capital Markets Securities Ltd

Β 

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Tekmar Group PLC

(c) Name of the party to the offer with which exempt principal trader is connected:

Tekmar Group PLC

(d) Date dealing undertaken:

30 December 2022

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

If YES, specify which:

Β 

Β 

Β 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

Β 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

Β 

The currency of all prices and other monetary amounts should be stated.

Β 

(a) Purchases and sales

Β 

Class of relevant security

Purchases/ sales

Β 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

Β 

ORD 1P

Β 

Β 

Sale

Β 

94,539

Β 

12.8p

Β 

11.2p

Β 

ORD 1P

Β 

Β 

Purchase

Β 

94,635

Β 

12.511p

Β 

10.8251p

Β 

(b) Cash-settled derivative transactions

Β 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

Β 

Β 

Β 

(c) Stock-settled derivative transactions (including options)

Β 

(i) Writing, selling, purchasing or varying

Β 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

Β 

(ii) Exercise

Β 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(d) Other dealings (including subscribing for new securities)

Β 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

Β 

Β 

Β 

Β 

Β 

Β 

3. OTHER INFORMATION

Β 

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

Β 

Β 

Β 

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

Β 

Β 

Β 

Β 

Date of disclosure:

03 January 2023

Contact name:

Jennifer Bentick

Telephone number:

020 7496 3055

Β 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.Β 

Β 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

Β 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
FERUOVAROWUARAR
Date   Source Headline
17th Feb 20257:00 amRNSAppointment of Chief Operating Officer
7th Feb 20253:05 pmRNSHolding(s) in Company
3rd Feb 20257:00 amRNSDirectorate Change
31st Jan 20257:00 amRNSPDMR Dealing
28th Jan 20252:30 pmRNSHolding(s) in Company
28th Jan 20257:00 amRNSDirector Share Purchase
27th Jan 20257:00 amRNSOffshore Wind Contract Award
22nd Jan 20254:26 pmRNSHolding(s) in Company
21st Jan 20257:00 amRNS-RInvestor Presentation via Investor Meet Company
7th Jan 20252:50 pmRNSIssue of Equity, PDMR Dealings and TVR
2nd Dec 20247:00 amRNSTrading and Strategy Update
18th Nov 20247:00 amRNSContract Award
5th Nov 20247:00 amRNSChange of Adviser
1st Nov 202412:24 pmRNSAIM Rule 17 Notification
24th Oct 20245:21 pmRNSAIM Rule 17 Notification
6th Sep 202411:08 amRNSHolding(s) in Company
2nd Sep 20247:00 amRNSConfirmation of CEO appointment
19th Aug 20244:37 pmRNSHolding(s) in Company
12th Aug 20247:00 amRNSDirectorate Changes
22nd Jul 20243:24 pmRNSREPLACEMENT: Exercise of Options and TVR
22nd Jul 20247:00 amRNSExercise of Options and Total Voting Rights
4th Jul 20246:01 pmRNSHolding(s) in Company
4th Jul 20246:01 pmRNSHolding(s) in Company
4th Jul 20247:00 amRNSRenewal of Banking Facilities
3rd Jul 20247:00 amRNSNew Contract Award
26th Jun 20241:30 pmRNSHolding(s) in Company
24th Jun 20247:00 amRNSCEO Appointment & Board Changes
13th Jun 20247:00 amRNSGrant of Conditional Share Options
5th Jun 20242:47 pmRNSHolding(s) in Company
17th May 20247:00 amRNSInvestor Presentation via Investor Meet Company
15th May 20247:00 amRNSInterim Results
3rd May 20247:00 amRNSDisposal of Subsea Innovation Limited
8th Apr 20247:00 amRNSContract Awards
27th Mar 202412:53 pmRNSResult of AGM
4th Mar 20247:05 amRNSNotice of AGM
4th Mar 20247:00 amRNSFinal Results
4th Jan 20247:00 amRNSNew Contract Award
16th Nov 20237:00 amRNSNew Contract Award
14th Nov 20237:00 amRNSAcquisition of minority interest
19th Sep 20237:41 amRNSExercise of Options and Total Voting Rights
28th Jul 20237:00 amRNSExtension of Banking Facilities
21st Jun 20237:01 amRNSInterim Results
21st Jun 20237:00 amRNSDirectorate Change
31st May 20237:00 amRNSNew Contract Award
3rd May 20238:34 amRNSForm 8.5 (EPT/NON-RI)
2nd May 20239:21 amRNSForm 8.5 (EPT/NON-RI)
26th Apr 20239:12 amRNSForm 8.5 (EPT/NON-RI)
21st Apr 20233:05 pmRNSHolding(s) in Company
21st Apr 20233:03 pmRNSHolding(s) in Company
21st Apr 20233:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.